1. Home
  2. LMND vs APGE Comparison

LMND vs APGE Comparison

Compare LMND & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lemonade Inc.

LMND

Lemonade Inc.

HOLD

Current Price

$57.50

Market Cap

4.0B

Sector

Finance

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$81.34

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMND
APGE
Founded
2015
2022
Country
United States
United States
Employees
1282
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
4.7B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
LMND
APGE
Price
$57.50
$81.34
Analyst Decision
Buy
Strong Buy
Analyst Count
7
13
Target Price
$70.86
$109.67
AVG Volume (30 Days)
1.6M
556.4K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$65.20
N/A
Revenue Next Year
$33.31
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.50
$34.34
52 Week High
$99.90
$95.32

Technical Indicators

Market Signals
Indicator
LMND
APGE
Relative Strength Index (RSI) 49.84 46.42
Support Level $52.26 $80.52
Resistance Level $58.56 $86.42
Average True Range (ATR) 2.81 3.93
MACD 0.32 -0.55
Stochastic Oscillator 88.66 46.23

Price Performance

Historical Comparison
LMND
APGE

About LMND Lemonade Inc.

Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. The Company operates in one report segment providing personal property and casualty insurance products within the United States and Europe, including the UK.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: